Shock: Pathophysiology of Circulatory Failure
Shock is a state of acute circulatory failure resulting in inadequate tissue perfusion and cellular oxygen delivery. It is not defined by blood pressure alone, but by the inability of the cardiovascular system to meet metabolic demands. Regardless of cause, all forms of shock lead to impaired oxygen utilisation, cellular energy failure, and organ dysfunction. Shock represents a final common pathway of physiological collapse across multiple disease processes. Understanding the pathophysiology of shock is essential for recognising early deterioration, guiding targeted interventions, and preventing progression to organ failure and death..
What You Need to Know
Shock is a state of acute circulatory failure resulting in inadequate tissue perfusion and cellular hypoxia. It occurs when the circulatory system can no longer deliver sufficient oxygen and nutrients to meet metabolic demand or remove metabolic waste. This failure may arise from disruption in one or more core components of circulation, including:
circulating blood volume
cardiac output
vascular tone
effective microcirculatory flow
In the early stages of shock, compensatory mechanisms attempt to preserve perfusion to vital organs. These responses include tachycardia, peripheral vasoconstriction, and activation of neurohormonal pathways such as the sympathetic nervous system and renin–angiotensin–aldosterone system. While initially protective, these responses increase myocardial workload and oxygen demand while reducing perfusion to skin, kidneys, and gastrointestinal tissues.
As shock progresses, compensation becomes inadequate. Reduced tissue perfusion leads to cellular hypoxia, a shift to anaerobic metabolism, and lactate accumulation. At this stage, dysfunction occurs not only at the systemic level but also within the microcirculation, where capillary flow becomes uneven and oxygen delivery to cells is impaired despite acceptable blood pressure readings.
Key features of established shock include:
impaired oxygen delivery and utilisation
rising lactate levels indicating anaerobic metabolism
progressive organ dysfunction
failure of compensatory mechanisms
If uncorrected, ongoing hypoperfusion results in widespread cellular injury, mitochondrial dysfunction, and loss of membrane integrity. This progression leads to multi-organ failure and, ultimately, death. Shock is therefore a dynamic and rapidly evolving condition that requires early recognition and intervention to prevent irreversible tissue damage.
Beyond the Basics
Impaired oxygen delivery
Oxygen delivery depends on three main factors: how much blood the heart pumps, how much oxygen the blood can carry, and how well that blood reaches tissues. In shock, this system breaks down early. Cardiac output may fall due to pump failure, reduced preload, or excessive afterload. In other forms of shock, cardiac output may be preserved or even elevated, but blood is poorly distributed and bypasses critical tissues.
Even when haemoglobin levels and oxygen saturation appear normal, inadequate flow means tissues do not receive enough oxygen. Cells switch from aerobic to anaerobic metabolism, producing lactate as a by-product. Rising lactate is therefore not just a marker of low oxygen, but of failed oxygen delivery relative to demand. The longer this imbalance persists, the harder it becomes to reverse.
Microcirculatory dysfunction
Shock is not solely a macrocirculatory problem. Blood pressure and cardiac output can appear acceptable while tissue hypoxia worsens at the capillary level. Vasoconstriction, endothelial injury, and inflammatory activation disrupt normal capillary flow. Instead of smooth, evenly distributed perfusion, blood becomes unevenly shunted through some areas while other capillary beds collapse entirely.
This results in heterogeneous perfusion where some cells receive excess oxygen while adjacent cells are critically hypoxic. Because oxygen extraction depends on close contact between red blood cells and tissues, this disordered flow severely limits effective oxygen uptake. This explains why improving blood pressure alone does not always restore organ function in shock.
Cellular energy failure
Mitochondria are central to shock pathophysiology. These organelles generate ATP through oxidative phosphorylation, a process that requires oxygen. In shock, reduced oxygen delivery is compounded by direct mitochondrial dysfunction caused by inflammatory mediators, oxidative stress, and acidosis.
As ATP production falls, energy-dependent processes begin to fail. Sodium–potassium pumps lose function, intracellular calcium rises, and cell membranes lose integrity. Cells swell, metabolic pathways become disorganised, and programmed cell death pathways are activated. Importantly, this energy failure can persist even after circulation is restored, contributing to delayed organ failure.
Metabolic acidosis and inflammatory amplification
Anaerobic metabolism occurs when oxygen delivery to tissues is insufficient to support normal aerobic respiration. Cells shift from oxidative phosphorylation (which generates large amounts of ATP in the presence of oxygen) to anaerobic glycolysis, a less efficient pathway that produces only small amounts of ATP. During this process, pyruvate is converted into lactate so that glycolysis can continue, allowing limited energy production to be maintained.
As oxygen delivery remains inadequate, lactate begins to accumulate in the bloodstream because its production exceeds the body’s ability to clear it, primarily through the liver. This accumulation contributes to metabolic acidosis, lowering blood pH. Acidosis is not just a biochemical abnormality, it has direct physiological consequences, impairing myocardial contractility, reducing responsiveness to catecholamines, and promoting vasodilation, which further worsens tissue perfusion and perpetuates the cycle of shock. Myocardial contractility decreases, reducing cardiac output further. Blood vessels become less responsive to catecholamines, making vasopressors less effective.
At the same time, hypoxic and injured tissues release inflammatory mediators. These increase vascular permeability, allowing fluid to leak into the interstitial space and worsening intravascular depletion. Inflammatory activation also promotes microthrombus formation, further impairing capillary flow. This creates a vicious cycle where hypoperfusion drives inflammation, and inflammation worsens hypoperfusion.
Progression to organ dysfunction
Organs with high metabolic demand and limited tolerance to hypoxia are affected first. The kidneys are particularly vulnerable, with reduced perfusion leading to acute kidney injury (AKI) and oliguria. The brain is sensitive to even brief reductions in oxygen delivery, resulting in altered consciousness and agitation early in shock. The heart suffers from impaired coronary perfusion, reducing contractility and accelerating circulatory collapse. In the lungs, increased capillary permeability contributes to pulmonary oedema and impaired gas exchange.
Initially, organ dysfunction may be reversible if perfusion is restored promptly. However, sustained hypoxia and cellular injury lead to structural damage and loss of function. Once multiple organ systems fail, mortality rises sharply. Shock is a time-critical condition and early intervention is more effective than late rescue.
Clinical Connections
Shock frequently develops before hypotension is present, making early recognition challenging. Compensatory mechanisms can maintain blood pressure despite significant impairment in tissue perfusion. As a result, relying on hypotension as a trigger delays diagnosis and escalation, allowing cellular injury to progress unchecked.
Early clinical indicators of shock relate to perfusion failure rather than pressure failure, and often appear across multiple systems:
Tachycardia reflecting sympathetic compensation
Altered mental state due to reduced cerebral perfusion
Reduced urine output from declining renal blood flow
Rising serum lactate indicating anaerobic metabolism
These changes may evolve gradually and are often subtle, particularly in older adults or patients with chronic illness. Their significance lies in trend recognition, not single observations.
Assessment. Shock assessment requires continuous synthesis of data rather than task-based observations. A patient whose heart rate is rising, urine output is falling, and cognition is subtly changing is demonstrating circulatory failure even if blood pressure remains within normal limits. Early recognition depends on understanding shock as a dynamic pathophysiological process, not a late haemodynamic endpoint.
Screening. Screening for shock risk is therefore essential in acute care settings. Patients with sepsis, haemorrhage, trauma, major surgery, dehydration, cardiac disease, or acute illness should be assessed proactively for evolving perfusion deficits. This includes repeated evaluation of vital signs, urine output, mental state, skin perfusion, and biochemical markers such as lactate.
Diagnosis. Shock is diagnosed through a combination of clinical assessment and supportive investigations, rather than a single definitive test. Bedside findings are integrated with laboratory markers (such as lactate and acid–base status), imaging where indicated, and haemodynamic assessment to identify both the presence of shock and its underlying cause.
Prompt recognition and escalation directly influence outcomes. Early identification allows timely intervention before irreversible organ injury occurs, reinforcing the importance of vigilance, clinical reasoning, and early communication in preventing progression to decompensated shock.
Concept Check
Why is shock defined by inadequate tissue perfusion rather than hypotension?
How does microcirculatory dysfunction contribute to organ failure?
Why can oxygen delivery appear normal while cellular hypoxia persists?
How does metabolic acidosis worsen circulatory failure?
Why are some organs affected earlier than others in shock?